Randomized trial for prevention of post ERCP pancreatitis with celecox tablets
Not Applicable
- Conditions
- post ERCP pancreatitis
- Registration Number
- JPRN-UMIN000012964
- Lead Sponsor
- Osaka City University Graduate School of Medicine
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- All
- Target Recruitment
- 170
Inclusion Criteria
Not provided
Exclusion Criteria
Patients who have severe heart disease, hepatic insufficiency, renal dysfunction, endocrine disease, or gastrointestinal tract disturbance. Patients with acute or chronic pancreatitis which need fasting therapy. Patients who take NSAIDs usually. Patients with a history of asthma of aspirin and allergia of iodine. Patients who performed operation of reconstraction for intestinal track by gastorectomy. Patients without informed consent. Patients who are judged inappropriate by chief (responsive) medical examiner.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method